Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2011 Financial Results
Date:11/2/2011

SOUTH SAN FRANCISCO, Calif., Nov. 2, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today reported its financial results for the third quarter 2011. Onyx reported a non-GAAP net loss of $19.5 million, or $0.31 per diluted share, for the third quarter 2011 compared to a non-GAAP net income of $55.3 million, or $0.84 per diluted share, for the same period in 2010. A description of the non-GAAP calculations is provided below in the accompanying table entitled "Reconciliation of GAAP to Non-GAAP Net Income (Loss)."

"We are continuing our strong momentum in 2011, building two robust oncology platforms – one in kinase inhibition and the other in proteasome inhibition," said N. Anthony Coles, M.D., president and chief executive officer of Onyx. "The submission of our new drug application for carfilzomib demonstrates our commitment to getting this important therapy to patients as quickly as possible. For the kinase inhibitor business, Nexavar delivered another quarter of solid operating performance, primarily driven by sales growth in the Asia Pacific and U.S. regions, and we continue to see even more opportunity with this therapy in the approved indications and, potentially, other tumor types. The recent Bayer settlement also gives us a significant interest in regorafenib, and with a successful pivotal trial in colorectal cancer, we are excited about the prospect of this new therapy for patients."

Recent business highlights include submission of the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) during September 2011 under the accelerated approval process for carfilzomib, and the restructuring of our partnership with Bayer HealthCare Pharmaceuticals Inc., or Bayer, during October 2011 for the global development and marketing of Nexavar® (sorafenib) tablets. The Company also entered into a new agreement with Bayer related
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  A recently published clinical study conducted at TOPS ... , demonstrates that 3D mammography (breast tomosynthesis) significantly reduces ... The study, "Implementation of Breast Tomosynthesis in a ... Stephen L. Rose , MD, and ... Journal of Roentgenology (AJR). The AJR is the ...
(Date:5/23/2013)... 23, 2013 Anthem Blue Cross patients with ... required them to obtain their medications by mail order ... Whatley Kallas LLC.  The lawsuit, filed ... Blue Cross,s mandatory mail order program announced late last ... privacy. "This settlement brings to a close ...
(Date:5/23/2013)... TARRYTOWN, N.Y. , May 23, 2013 /PRNewswire/ ... reconstruction following mastectomy is an appropriate option ... mutations seeking to surgically reduce their breast cancer ... involves a gradual expansion process and a second ... of implants in the same surgery as mastectomy ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3
(Date:5/24/2013)... KC and Monica Craichy, Founders of Living ... oldest sons, Kyle and Austin Craichy, will be kiteboarding with ... professional kiteboarders. , KC Craichy said he is excited to ... together such that virtually everyone who planned to be involved ... boarders will meet at Matheson Hammock Park and Beach in ...
(Date:5/24/2013)... With Memorial Day Weekend upon us, cookout season has officially ... to help prevent grill fires throughout the spring and summer. ... that gas grills led to an average of 7,100 home ... meanwhile, caused approximately 1,200 home fires per year during that ... the following tips from the NFPA to help protect your ...
(Date:5/24/2013)... The Mirena IUD lawyers at ... the FDA has received more than 59,229 complaints since 2004 ... intrauterine birth control device known as the Mirena IUD.* , ... by the women “included ‘expulsion,’ where the IUD came out ... according to an ABC News article. “Abdominal pain is also ...
(Date:5/24/2013)... May 24 (HealthDay News) -- New research suggests ... among people with insomnia. Every additional hour ... 72 percent drop in the likelihood of moderate ... from the University of Pennsylvania. "We ... between sleep duration and suicide risk," study author, ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 E-Dentists.com has ... in partnership with JD Media Surge, a leading medical ... The dental SEO analysis service will focus on providing ... the search engines for their competitive keywords. The dental ... website and recommendations based on what their competitors are ...
Breaking Medicine News(10 mins):Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 2Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 3Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes 2Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2
... study may help put to rest fears that pregnancy ... receiving antiretroviral therapy. The study, published in the October ... now available online, revealed that pregnancy may, in fact, ... advent of highly active antiretroviral therapy (HAART), many women ...
... Segal Health Plan Cost,Trend Survey forecasts continued declines in ... medical trends. And, although a growing,number of health plans ... still significantly above general inflation. Key findings,include: ... for point-of-service (POS) medical ...
... District,Court for the District of Massachusetts has granted ... a class of people and entities that,purchased certain ... Health Benefits Fund v. First DataBank, Inc., No.,1:05-CV-11148-PBS ... Medi-Span, No.,07-cv-10988-PBS, concerning how the published price of ...
... of parents feel they play a significant role in ... at the University of Michigan C.S. Mott Childrens Hospital. ... issue of the Journal of Pediatrics, 86 percent of ... their hospitalized childs medical care. Researchers also found that ...
... Medicine (BUSM), Boston University School of Public Health ... Institute (NHLBI), have completed analyses of a genome-wide ... participants from the landmark Framingham Heart Study (FHS). ... potentially affect the risk for cardiovascular disease and ...
... researchers say , , WEDNESDAY, Sept. 19 (HealthDay News) ... knew little or nothing about peripheral arterial disease (PAD), ... legs that boosts heart risk. , "I don,t think ... PAD," said Dr. Timothy Murphy, a professor of diagnostic ...
Cached Medicine News:Health News:Pregnancy may slow -- not accelerate -- progression to AIDS 2Health News:Pregnancy may slow -- not accelerate -- progression to AIDS 3Health News:Segal Survey Predicts Declines in Trends for Fifth Consecutive Year 2Health News:Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals 2Health News:Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals 3Health News:Parents' participation in medical decisions linked to self-efficacy 2Health News:Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits 2Health News:Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits 3Health News:Few Americans Know of Leg Artery Danger 2Health News:Few Americans Know of Leg Artery Danger 3
The Skull Pins are inserted into the receptacles of the Skull Clamp and fixate the head during surgery....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
Mayfield radiolucent skull clamp....
... for general applications and are equipped with our ... i.e. rigid endoscopes, range between 1 mm and ... to a 120 retrospection, and image angles ranging ... Endoscopes with working lengths of 1.5 meters and ...
Medicine Products: